Company Analysis

Clene Inc. (CLNN)

Nasdaq: CLNN · Pharmaceutical Preparations · Salt Lake City, UT · filing with the SEC since 2020
Grade3.0
◀ Past 3.1● Present 3.1▶ Future 2.7
1 est.

Who runs Clene Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Etherington Robert Dee
President & CEO. First filing Jan 2021, latest Oct 21, 2026, 3 filings in all.
Officers reporting now
3
of 12 people with a filing in the last fifteen months
Directors reporting now
9
16 people on the record since 2021
Officerssales are open-market, Oct 21, 2025 to Oct 21, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Etherington Robert DeePresident & CEOJan 2021Oct 21, 2026none
Brown Morgan RChief Financial OfficerFeb 2022Oct 21, 2026none
Mortenson MarkChief Science OfficerJan 2021Oct 21, 2026none
Directorssales are open-market, Oct 21, 2025 to Oct 21, 2026
NameRoleFirst filingLatest filingSales, 12 months
Matlin David JdirectorJan 2021Sep 18, 2026none
Mosca AlisondirectorJan 2021Sep 18, 2026none
Desai Arjun JjdirectorSep 2023Aug 14, 2026none
Gay JonathondirectorJan 2021Aug 14, 2026none
Jacobovitz ShalomdirectorJan 2021Aug 14, 2026none
Kiernan MatthewdirectorSep 2023Aug 14, 2026none
Mclaughlin ValleriedirectorAug 2021Aug 14, 2026none
Wilcox Reed NdirectorJan 2021Aug 14, 2026none
Ugwumba ChidoziedirectorJan 2021Aug 6, 202662 · $5.8M
Owners of more than 10% of a classsales are open-market, Oct 21, 2025 to Oct 21, 2026
NameRoleFirst filingLatest filingSales, 12 months
General Resonance LLC10% ownerJul 2021Aug 21, 2025none
Earlier names on the record5, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton CLNN · research, not advice